TickerFacts.

Oruka Therapeutics, Inc. (ORKA): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Older than the company's other figures. The latest EBITDA is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$7.28M
Year ended 2023-12-31
2010-12-31: -$8.84M2011-12-31: -$6.76M2012-12-31: -$4.28M2013-12-31: -$6.91M2014-12-31: -$9.68M2015-12-31: -$11.44M2016-12-31: -$16.59M2017-12-31: -$18.68M2018-12-31: -$8.10M2019-12-31: -$5.80M2020-12-31: -$9.76M2021-12-31: -$19.32M2022-12-31: -$10.58M2023-12-31: -$7.28M-$7.28M
2010-12-31 EBITDA (USD) 2023-12-31
Period endedEBITDAChange YoYSource filing
2023-12-31-$7.28Mn/m2024-02-01, From 2023-01-01
2022-12-31-$10.58Mn/m2024-02-01, From 2022-01-01
2021-12-31-$19.32Mn/m2023-02-24, From 2021-01-01
2020-12-31-$9.76Mn/m2022-03-14, From 2020-01-01
2019-12-31-$5.80Mn/m2021-03-18, From 2019-01-01
2018-12-31-$8.10Mn/m2020-02-18, From 2018-01-01
2017-12-31-$18.68Mn/m2019-02-27, From 2017-01-01
2016-12-31-$16.59Mn/m2018-03-22, From 2016-01-01
2015-12-31-$11.44Mn/m2017-03-21, From 2015-01-01
2014-12-31-$9.68Mn/m2016-03-17, From 2014-01-01
2013-12-31-$6.91Mn/m2015-03-19, From 2013-01-01
2012-12-31-$4.28Mn/m2014-03-20, From 2012-01-01
2011-12-31-$6.76Mn/m2013-03-21, From 2011-01-01
2010-12-31-$8.84Mn/a2012-03-27, From 2010-01-01